Korea's Cha, Israel's Pluristem in mutual share investment
December 17, 2013 at 04:06 AM EST
TEL AVIV, Dec 17 (Reuters) - Israel's Pluristem Therapeutics Inc issued 2.5 million shares to South Korea-based Cha Bio&Diostech in return for 1.01 million shares of Cha, reflecting a total investment of $10.4 million.
